Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 32–32 | Cite as

Alemtuzumab

Aggravation of multiple sclerosis: case report
Case report
  • 14 Downloads

Reference

  1. Baumgartner R, et al. One unexpected increase in clinical and MRI disease activity after first course of Alemtuzumab besides many positive outcomes. Swiss Medical Weekly 146 (Suppl. 219): 97S, Sep 2016. Available from: URL: https://smw.ch/ [abstract] - SwitzerlandGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations